Competition commission exposes dark side of distribution in Indian pharmacy indictment
This article was originally published in Scrip
In a stinging indictment, the Competition Commission of India (CCI) has held the country’s pharmacy association, the All India Organisation of Chemists and Druggists (AIOCD), guilty of a slew of unfair practices, exposing what is perhaps the seamy underbelly of the distribution trade.
You may also be interested in...
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.